FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes

PMA: P830061 · Supplement: S175 · Decision Sep 27, 2019
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
Trade Name
CapSure Sense Leand and CapSure SP Novus Lead
PMA Number
P830061
Supplement Number
S175
Device Class
FDA Class 3
Product Code
NVN
Generic Name
Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
September 27, 2019
Date Received
September 16, 2019
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Transfer of receiving and incoming inspection activities from Medtronic Rice Creek facility to the Medtronic Puerto Rico Operations Company (MPROC) Villalba, MPROC Juncos, and the Federal Express/Third Party Logistics facility in Guaynabo, Puerto Rico.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NVN Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes